Table of Contents Author Guidelines Submit a Manuscript
Table of Contents Alerts

To receive news and publication updates for Case Reports in Hematology, enter your email address in the box below.

Case Reports in Hematology
Volume 2014, Article ID 642868, 6 pages
http://dx.doi.org/10.1155/2014/642868
Case Report

Refractory Classical Hodgkin Lymphoma Presenting with Atypical Cutaneous Involvement and Diagnosis of ZZ Phenotype Alpha-1 Antitrypsin Deficiency

Mohamad Khawandanah,1 Teresa Kraus,2 and Mohamad Cherry1

1Hematology-Oncology Section, Department of Medicine, Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, 800 NE 10th Street, Oklahoma City, OK 73104, USA
2Department of Pathology, The University of Oklahoma Health Sciences Center, 940 Stanton L. Young Boulevard, BMSB 451, Oklahoma City, OK 73104, USA

Received 10 February 2014; Revised 21 April 2014; Accepted 23 April 2014; Published 13 May 2014

Academic Editor: Marie-Christine Kyrtsonis

Copyright © 2014 Mohamad Khawandanah et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, and M. J. Thun, “Cancer statistics, 2009,” CA: Cancer Journal for Clinicians, vol. 59, no. 4, pp. 225–249, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. E. Campo, S. H. Swerdlow, N. L. Harris et al., “Hodgkin lymphoma,” in WHO, Classification of Tumours of Haematopoietic and Lymphoid Tissues, International Agency for Research on Cancer, Lyon, France, 4th edition, 2008. View at Google Scholar
  3. A. Fernandez-Flores, “The early reports on cutaneous involvement by hodgkin lymphoma,” American Journal of Dermatopathology, vol. 31, no. 8, pp. 853–854, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Kumar, D. W. Kingma, W. B. Weiss et al., “Primary cutaneous Hodgkin's disease with evolution to systemic disease. Association with the Epstein-Barr virus,” The American Journal of Surgical Pathology, vol. 20, pp. 754–759, 1996. View at Google Scholar
  5. C. E. Introcaso, J. Kantor, D. L. Porter, and J. M. Junkins-Hopkins, “Cutaneous Hodgkin's disease,” Journal of the American Academy of Dermatology, vol. 58, no. 2, pp. 295–298, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. R. M. White and J. W. Patterson, “Cutaneous involvement in Hodgkin's disease,” Cancer, vol. 55, no. 5, pp. 1136–1145, 1985. View at Google Scholar · View at Scopus
  7. J. K. Stoller and M. Brantly, “The challenge of detecting alpha-1 antitrypsin deficiency,” Chronic Obstructive Pulmonary Disease, vol. 10, supplement 1, pp. 26–34, 2013. View at Google Scholar
  8. R. A. Sandhaus and G. Turino, “Neutrophil elastase-mediated lung disease,” Chronic Obstructive Pulmonary Disease, vol. 10, supplement 1, pp. 60–63, 2013. View at Google Scholar
  9. G. Bonadonna, R. Zucali, and S. Monfardini, “Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP,” Cancer, vol. 36, no. 1, pp. 252–259, 1975. View at Google Scholar · View at Scopus
  10. A. Younes, A. K. Gopal, S. E. Smith et al., “Results of a pivotal phase II study of brentuximab vedotin for patients with relapsed or refractory Hodgkin's lymphoma,” Journal of Clinical Oncology, vol. 30, pp. 2183–2189, 2012. View at Google Scholar
  11. A. J. Moskowitz, P. A. Hamlin Jr., M. A. Perales et al., “Phase II study of bendamustine in relapsed and refractory Hodgkin lymphoma,” Journal of Clinical Oncology, vol. 31, pp. 456–460, 2013. View at Google Scholar
  12. A. K. Gopal, O. W. Press, A. R. Shustov et al., “Efficacy and safety of gemcitabine, carboplatin, dexamethasone, and rituximab in patients with relapsed/refractory lymphoma: a prospective multi-center phase II study by the Puget Sound Oncology Consortium,” Leukemia and Lymphoma, vol. 51, no. 8, pp. 1523–1529, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. American Thoracic Society and European Respiratory Society, “American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency,” The American Journal of Respiratory and Critical Care Medicine, vol. 168, pp. 818–900, 2003. View at Google Scholar
  14. F. Callea, G. Massi, and C. De Wolf-Peeters, “Alpha-1-antitrypsin phenotypes in malignant lymphoma,” Journal of Clinical Pathology, vol. 35, no. 11, pp. 1213–1215, 1982. View at Google Scholar · View at Scopus
  15. P. Yang, Z. Sun, M. J. Krowka et al., “Alpha1-antitrypsin deficiency carriers, tobacco smoke, chronic obstructive pulmonary disease, and lung cancer risk,” Archives of Internal Medicine, vol. 168, no. 10, pp. 1097–1103, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Yang, W. R. Bamlet, Z. Sun et al., “Alpha1-antitrypsin and neutrophil elastase imbalance and lung cancer risk,” Chest, vol. 128, pp. 445–452, 2005. View at Google Scholar
  17. Z. Sun and P. Yang, “Role of imbalance between neutrophil elastase and α1-antitrypsin in cancer development and progression,” Lancet Oncology, vol. 5, no. 3, pp. 182–190, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Bluefarb, Cutaneous Manifestations of the Malignant Lymphomas, vol. 219, Charles C Thomas, Springfield, Ill, USA, 1959.
  19. J. Rubins, “Cutaneous Hodgkin's disease. Indolent course and control with chemotherapy,” Cancer, vol. 42, no. 3, pp. 1219–1221, 1978. View at Google Scholar · View at Scopus
  20. L. Cerroni, C. Beham-Schmid, and H. Kerl, “Cutaneous Hodgkin's disease: an immunohistochemical analysis,” Journal of Cutaneous Pathology, vol. 22, no. 3, pp. 229–235, 1995. View at Publisher · View at Google Scholar · View at Scopus
  21. J. L. Smith Jr. and J. J. Butler, “Skin involvement in Hodgkin's disease,” Cancer, vol. 45, no. 2, pp. 354–361, 1980. View at Google Scholar · View at Scopus
  22. L. C. Goldberg, “Cutaneous Hodgkin's disease,” Cutis, vol. 17, no. 1, pp. 115–118, 1976. View at Google Scholar · View at Scopus
  23. R. M. MacKie, “Cutaneous lymphomas and lymphocytic infiltrates,” in Textbook of Dermatology, R. H. Champion, D. A. Burns, and S. M. Breathnach, Eds., vol. 3, pp. 2373–2402, Blackwell Science, Oxford, UK, 6th edition, 1998. View at Google Scholar
  24. A. Topic, Z. Juranic, S. Jelic, and I. G. Magazinovic, “Polymorphism of alpha-1-antitrypsin in hematological malignancies,” Genetics and Molecular Biology, vol. 32, no. 4, pp. 716–719, 2009. View at Publisher · View at Google Scholar · View at Scopus